- Investing Ideas
- /
- Top Rated Asian Stocks
Top Rated Asian Stocks
UPDATED Apr 16, 2024
Financially healthy companies listed on Asian stock exchanges with an impressive track record.
213 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
D4S | JP¥27.37 | -2.3% | -14.9% | JP¥8.7t | JP¥33.76 | PE47x | E21.9% | 1.3% | Pharmaceuticals & Biotech | ||
DC4 | US$127.40 | -0.9% | 17.6% | US$51.9b | US$141.35 | PE95.8x | E20.2% | n/a | Healthcare | ||
DC4 | US$128.48 | -0.2% | 18.9% | US$51.9b | US$142.54 | PE95.8x | E20.2% | n/a | Healthcare | ||
1N8 | €1,456.40 | -1.4% | -0.7% | €45.0b | €1,666.95 | PE64.4x | E19.8% | n/a | Diversified Financials | ||
1N8U | €14.20 | -3.4% | -1.4% | €45.0b | €16.25 | PE64.4x | E19.8% | n/a | Diversified Financials | ||
1N8 | €1,445.60 | -2.9% | -1.1% | €45.0b | €1,654.59 | PE64.4x | E19.8% | n/a | Diversified Financials | ||
TT8 | US$77.36 | -4.0% | 37.6% | US$40.1b | US$88.86 | PE224.3x | E30.9% | n/a | Media | ||
TT8 | US$77.08 | -3.9% | 37.4% | US$40.1b | US$88.54 | PE224.3x | E30.9% | n/a | Media | ||
49V | US$79.97 | 5.2% | 607.7% | US$30.8b | US$88.28 | PE67x | E31.6% | 0.1% | Capital Goods | ||
RHM | €544.60 | 3.3% | 100.4% | €23.6b | €540.34 | PE40.7x | E27.7% | 1.0% | Capital Goods | ||
RHM | €543.40 | 3.9% | 101.1% | €23.6b | €539.15 | PE40.7x | E27.7% | 1.0% | Capital Goods | ||
RHMB | €109.00 | 5.3% | 103.7% | €23.6b | €106.50 | PE41.4x | E27.7% | 1.0% | Capital Goods | ||
SWN | US$33.70 | 0% | -8.1% | US$21.6b | US$45.79 | PE26.1x | E26.4% | 0% | Transportation | ||
MHG | US$339.50 | -3.5% | 27.2% | US$21.1b | US$393.45 | PE19.4x | E14.7% | n/a | Healthcare | ||
KKS | US$103.00 | -6.4% | 66.1% | US$21.1b | US$145.32 | PE11.2x | E17.0% | 6.8% | Diversified Financials | ||
BM8 | US$87.32 | 9.0% | -4.4% | US$17.4b | US$104.99 | PE103.6x | E30.8% | n/a | Pharmaceuticals & Biotech | ||
BM8 | US$81.02 | 0% | -19.3% | US$16.7b | US$100.94 | PE113.6x | E34.0% | n/a | Pharmaceuticals & Biotech | ||
0PY | US$322.50 | 0% | -1.9% | US$15.7b | US$446.51 | PE49.6x | E18.0% | 0.6% | Commercial Services | ||
NSY | ₪214.00 | -2.7% | 9.7% | ₪54.5b | ₪255.72 | PE42.8x | E14.3% | 0% | Software | ||
NB3 | US$125.90 | -1.5% | 33.2% | US$13.3b | US$145.72 | PE53.1x | E26.7% | n/a | Pharmaceuticals & Biotech | ||
FO9A | ₺161.00 | 1.9% | 10.3% | ₺404.6b | ₺169.17 | PE8.2x | E16.5% | 2.6% | Automobiles | ||
ICY | US$50.18 | -1.1% | -25.1% | US$11.9b | US$71.71 | PE20x | E20.1% | n/a | Pharmaceuticals & Biotech | ||
01P | US$362.90 | -1.7% | 106.2% | US$11.9b | US$378.92 | PE42.2x | E14.7% | n/a | Pharmaceuticals & Biotech | ||
DJD | €101.00 | -1.9% | 20.2% | €10.8b | €122.03 | PE21.6x | E25.2% | 1.8% | Retail |